Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts

BACKGROUND: Purine nucleoside phosphorylase (PNP) gene transfer represents a promising approach to treatment of head and neck malignancies. We tested recombinant adenovirus already in phase I/II clinical testing and leading‐edge patient‐derived xenografts (PDX) as a means to optimize this therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rab, Regina, Ehrhardt, Annette, Achyut, Bhagelu R., Joshi, Disha, Gilbert‐Ross, Melissa, Huang, Chunzi, Floyd, Katharine, Borovjagin, Anton V., Parker, William B., Sorscher, Eric J., Hong, Jeong S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939994/
https://www.ncbi.nlm.nih.gov/pubmed/36253876
http://dx.doi.org/10.1002/cnr2.1708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939994/
https://www.ncbi.nlm.nih.gov/pubmed/36253876
http://dx.doi.org/10.1002/cnr2.1708

Ejemplares similares